Crystal structures of a multidrug transporter reveal a functionally rotating mechanism

Nature

Volumn 443, Issue 7108, 2006, Pages 173-179

  Murakami, Satoshi ^a,b,c   Nakashima, Ryosuke ^a   Yamashita, Eiki ^a   Matsumoto, Takashi ^a,b   Yamaguchi, Akihito ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c 313 Photonics Center Building   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CRYSTAL STRUCTURE; DRUG THERAPY; ESCHERICHIA COLI; PLASMAS; PROTEINS;

DRUG COMPLEXES; MULTIDRUG TRANSPORTER; PERIPLASMIC DOMAIN; ROTATING MECHANISM;

DRUG PRODUCTS;

GLYCOPROTEIN P; PERIPLASMIC PROTEIN; PROTEIN ACRB; UNCLASSIFIED DRUG;

BACTERIUM; CRYSTAL STRUCTURE; DRUG; PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; DRUG BINDING SITE; ESCHERICHIA COLI; MEMBRANE FUSION; PRIORITY JOURNAL; PROTEIN CONFORMATION;

ESCHERICHIA COLI;

EID: 33748670458     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05076     Document Type: Article

References (43)

1. Li, X. Z. & Nikaido, H. Efflux-mediated drug resistance in bacteria. Drugs 64, 159-204 (2004).
2. Ma, D. et al. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175, 6299-6313 (1993).
3. Ma, D. et al. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16, 45-55 (1995).
4. Sulavik, M. C. et al. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45, 1126-1136 (2001).
5. Nishino, K. & Yamaguchi, A. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183, 5803-5812 (2001).
6. Okusu, H., Ma, D. & Nikaido, H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants. J. Bacteriol. 178, 306-308 (1996).
7. Tseng, T.-T. et al. The RND permease superfamily: An ancient, ubiquitous and diverse family that includes human disease and development proteins. J. Mol. Microbiol. Biotechnol. 1, 107-125 (1999).
8. Touze, T. et al. Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system. Mol. Microbiol. 53, 697-706 (2004).
9. Poole, K. Multidrug resistance in Gram-negative bacteria. Curr. Opin. Microbiol. 4, 500-508 (2001).
10. Tikhonova, E. B. & Zgurskaya, H. I. AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J. Biol. Chem. 279, 32116-32124 (2004).
11. Zgurskaya, H. I. & Nikaido, H. Bypassing periplasm: Reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc. Natl Acad. Sci. USA 96, 7190-7195 (1999).
12. Nikaido, H. How do exported proteins and antibiotics bypass the periplasm in Gram-negative bacterial cells? Trends Microbiol. 8, 481-483 (2000).
13. Murakami, S., Nakashima, R., Yamashita, E. & Yamaguchi, A. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419, 587-593 (2002).
14. Murakami, S. & Yamaguchi, A. Multidrug-exporting secondary transporters. Curr. Opin. Struct. Biol. 13, 443-452 (2003).
15. Murakami, S., Tamura, N., Saito, A., Hirata, T. & Yamaguchi, A. Extramembrane central pore of multidrug exporter AcrB in Escherichia coli plays an important role in drug transport. J. Biol. Chem. 279, 3743-3748 (2004).
16. Tamura, N., Murakami, S., Oyama, Y., Ishiguro, M. & Yamaguchi, A. Direct interaction of multidrug efflux transporter AcrB and outer membrane channel TolC detected via site-directed disulfide cross-linking. Biochemistry 44, 11115-11121 (2005).
17. Koronakis, V., Sharff, A., Koronakis, E., Luisi, B. & Hughes, C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405, 914-919 (2000).
18. Mikolosko, J., Bobyk, K., Zgurskaya, H. I. & Ghosh, P. Conformational flexibility in the multidrug efflux system protein AcrA. Structure 14, 577-587 (2006).
19. Higgins, M. K., Bokma, E., Koronakis, E., Hughes, C. & Koronakis, V. Structure of the periplasmic component of a bacterial drug efflux pump. Proc. Natl Acad. Sci. USA 101, 9994-9999 (2004).
20. Akama, H. et al. Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem. 279, 25939-25942 (2004).
21. Yu, E. W., McDermott, G., Zgurskaya, H. I., Nikaido, H. & Koshland, D. E. Jr. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300, 976-980 (2003).
22. Mao, W. et al. On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: The large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Mol. Microbiol. 46, 889-901 (2002).
23. Schumacher, M. A. et al. Structural mechanisms of QacR induction and multidrug recognition. Science 294, 2158-2163 (2001).
24. Schumacher, M. A. & Brennan, R. G. Structural mechanisms of multidrug recognition and regulation by bacterial multidrug transcription factors. Mol. Microbiol. 45, 885-893 (2002).
25. Grkovic, S., Hardie, K. M., Brown, M. H. & Skurray, R. A. Interactions of the QacR multidrug-binding protein with structurally diverse ligands: Implications for the evolution of the binding pocket. Biochemistry 42, 15226-15236 (2003).
26. Burley, S. K. & Petsko, G. A. Aromatic-aromatic interaction: A mechanism of protein structure stabilization. Science 229, 23-28 (1985).
27. Thanassi, D. G., Cheng, L. W. & Nikaido, H. Active efflux of bile salts by Escherichia coli. J. Bacteriol. 179, 2512-2518 (1997).
28. Guan, L. & Nakae, T. Identification of essential charged residues in transmembrane segments of the multidrug transporter MexB of Pseudomonas aeruginosa. J. Bacteriol. 183, 1734-1739 (2001).
29. Abramson, J. et al. Structure and mechanism of the lactose permease of Escherichia coli. Science 301, 610-615 (2003).
30. Boyer, P. D. A perspective of the binding change mechanism for ATP synthesis. FASEB J. 3, 2164-2178 (1989).
31. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
32. Navaza, J. AMoRe: An automated package for molecular replacement. Acta Crystallogr. A 50, 157-163 (1994).
33. Collaborative Computational Project, Number 4. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
34. de La Fortelle, E. & Bricogne, G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276, 472-494 (1997).
35. Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
36. Yao, M., Zhou, Y. & Tanaka, I. LAFIRE: Software for automating the refinement process of protein-structure analysis. Acta Crystallogr. D 62, 189-196 (2006).
37. Brünger, A. T. et al. Crystallography & NMR System: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
38. Murshudov, G. N., Vagin, A. A., Lebedev, A., Wilson, K. S. & Dodson, E. J. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr. D 55, 247-255 (1999).
39. Kraulis, P. J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950 (1991).
40. Esnouf, R. M. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr. D 55, 938-940 (1999).
41. Merritt, E. A. & Bacon, D. J. Raster3D: Photorealistic molecular graphics. Methods Enzymol. 277, 505-524 (1997).
42. Kleywegt, G. J. & Jones, T. A. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D 50, 178-185 (1994).
43. Kleywegt, G. J. & Jones, T. A. Software for handling macromolecular envelopes. Acta Crystallogr. D 55, 941-944 (1999).